We calculated a second, separate immunocytochemical measure of tumor infiltration by quantifying high-grade glioma cells that were positive for either nestin or for IDH1 (R132H) mutant protein at the core and tumor edge (Figure 4A and B). Here, IDH1 is linked to central nervous system cancer.